Panelists discuss how differentiating primary from secondary erythrocytosis is crucial in guiding treatment strategies, emphasizing the importance of addressing underlying causes such as chronic ...

Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs), whether defined as lack of hemoglobin response to typical ESA doses or need for higher ESA doses to reach hemoglobi ...

Panelists discuss how hepcidin mimetics like rusfertide offer a novel approach to managing polycythemia vera (PV) by ...

Erythropoietin is an endogenous hormone of glicoproteic nature secreted by the kidneys and is the main regulator of the erythropoiesis. An alteration in its production generates a disturbance in the ...

Erythroblast Island Macrophages (EIMs) are specialized cells that play a crucial role in erythropoiesis by forming erythroblastic islands (EBIs) and supporting the maturation of erythroblasts. These ...

The authors measured serum iron metabolism biomarkers at baseline, 12 weeks and 52 weeks to characterize the inter-relationships of these biomarkers with clinical status and with the effect of ...